logo
  

Novavax Announces Submission Of COVID-19 Vaccine To WHO For Emergency Use Listing

Novavax, Inc. (NVAX), with its partner, Serum Institute of India, announced a regulatory submission to the World Health Organization for emergency use listing of Novavax' protein-based COVID-19 vaccine candidate. The grant of emergency use listing by the WHO is a prerequisite for exports to numerous countries participating in the COVAX Facility.

"Today's submission is a significant step on the path to accelerating access and more equitable distribution to countries in great need around the world," said Stanley Erck, President and CEO, Novavax.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Sandoz, Inc., an unit of Novartis AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high temperatures that may have impacted product effectiveness, the U.S. Food and Drug Administration or FDA said in a statement. Livia Global, Inc., a health and wellness company, is recalling two lots of its Liviaone liquid probiotics citing the possibility of contamination by Pseudomonas aeruginosa, the U.S. Food and Drug Administration said. Pseudomonas aeruginosa is a microorganism found in the environment that, if ingested, can cause life-threatening infection in immunocompromised individuals. United Airlines operated Thursday the first ever passenger flight using 100% Sustainable Aviation Fuel or SAF as part of its efforts to combat climate change. The airline flew the green flight from Chicago's O'Hare International Airport or ORD to Washington, D.C.'s Reagan National Airport or DCA with more than 100 passengers.
Follow RTT